FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy
Published on
![](https://www.chop.edu/sites/default/files/lab-photo-780x439.jpg)
For decades, doctors and researchers have been working diligently to discover new treatments and provide more options for patients with Duchenne muscular dystrophy (DMD), a debilitating genetic disease that ravages the muscles in the body and leads to a loss of movement and coordination.